Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agoni (Q42647989)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agoni |
scientific article |
Statements
1 reference
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agoni (English)
1 reference
Linus S Lin
1 reference
Sookhee Ha
1 reference
Richard G Ball
1 reference
Nancy N Tsou
1 reference
Laurie A Castonguay
1 reference
George A Doss
1 reference
Tung M Fong
1 reference
Chun-Pyn Shen
1 reference
Jing Chen Xiao
1 reference
Mark T Goulet
1 reference
William K Hagmann
1 reference
12 March 2008
1 reference
1 reference
Identifiers
1 reference